NBIX is worth $50 today just based on Pfizer Indiplon deal and Pending FDA approval. Approval and Launch is worth another $25 in price per share within 6 months. IMO given cash position of NBIX investors get the rest of the pipeline for "FREE". or another way of looking at it $50 plus $10 per share cash = $60 bucks its current trading price. Peak sales for Indiplon via sell-side analyst could be as high as $2B with the Pfizer Marketing Machine driving Sales. With both an IR & MR formulations and different Mg versions Pfizer is going to focus on personalized patient care.